Efficacy of antimicrobial medicated ventricular catheters: a network meta-analysis with trial sequential analysis

Revanth Goda1, Akshay Ganeshkumar1, Varidh Katiyar1

  • 1Department of Neurosurgery, All India Institute of Medical Sciences, New Delhi, India.

Insights

Antibiotic-medicated (AM) ventricular catheters significantly reduce infection rates compared to non-medicated (NM) ones, but more evidence is needed. Silver-medicated (SM) catheters were less effective than AM and similar to NM, with AM shunts not impacting reoperation rates.

Area of Science:

  • Neurosurgery
  • Infectious Diseases
  • Medical Device Technology

Background:

  • Ventricular catheter infections pose significant risks in neurosurgery.
  • The comparative efficacy of antibiotic-medicated (AM), silver-medicated (SM), and non-medicated (NM) catheters for infection control is not well-established.
  • Recent trials necessitate updated evidence synthesis.

Purpose of the Study:

  • To quantitatively synthesize evidence on the infection rates associated with AM, SM, and NM ventricular catheters.
  • To assess the need for further research using trial sequential analysis (TSA).
  • To incorporate indirect evidence through network meta-analysis (NMA).

Main Methods:

  • Systematic review and network meta-analysis (NMA) of randomized controlled trials (RCTs).
  • Inclusion of trials comparing AM, SM, and NM ventricular shunts (VPS) or external ventricular drains (EVD).
  • Trial sequential analysis (TSA) to evaluate the certainty of evidence and need for further trials.

Main Results:

  • Antibiotic-medicated VPS demonstrated a significantly lower infection rate than non-medicated VPS (RR 0.44; 95% CI: 0.27-0.73).
  • Trial sequential analysis indicated a need for further evidence regarding infection rates.
  • Silver-medicated catheters were inferior to antibiotic-medicated ones and showed no significant difference compared to non-medicated catheters.
  • Network meta-analysis for VPS showed antibiotic-medicated catheters were superior to both silver-medicated (RR 0.41, 95% CI: 0.22-0.75) and non-medicated (RR 0.42; 95% CI: 0.25-0.71) options.
  • Antibiotic-medicated shunts did not significantly affect reoperation rates (RR 0.99; 95% CI:0.81-1.20).

Conclusions:

  • Antibiotic-medicated ventricular catheters are effective in reducing infection rates compared to non-medicated options.
  • Further research is warranted to confirm these findings definitively.
  • Silver-medicated catheters do not offer a significant advantage over non-medicated ones and are inferior to antibiotic-medicated catheters for infection prevention.